Oxytocin And Uterotonic Agent Use For Cesarean Delivery
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The central objective of this study will be to evaluate a standardized, evidence-based
regimen versus a conventional regimen for uterotonic drug dosing for elective cesarean
delivery
The investigators primary hypothesis is that the proposed uterotonic drug regimen, when
compared to conventional dosing regimen, during elective cesarean delivery will:
1. Reduce the overall amount of oxytocin and other uterotonic agents used to obtain
satisfactory uterine tone.
Secondary outcomes to be evaluated will be:
1. Reduce the side effects associated with uterotonic drug use
2. Reduce the time to establishment and maintenance of adequate uterine tone